[go: up one dir, main page]

GB201501612D0 - Assay - Google Patents

Assay

Info

Publication number
GB201501612D0
GB201501612D0 GBGB1501612.4A GB201501612A GB201501612D0 GB 201501612 D0 GB201501612 D0 GB 201501612D0 GB 201501612 A GB201501612 A GB 201501612A GB 201501612 D0 GB201501612 D0 GB 201501612D0
Authority
GB
United Kingdom
Prior art keywords
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1501612.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Birmingham
Original Assignee
University of Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Birmingham filed Critical University of Birmingham
Priority to GBGB1501612.4A priority Critical patent/GB201501612D0/en
Publication of GB201501612D0 publication Critical patent/GB201501612D0/en
Priority to PCT/GB2016/050199 priority patent/WO2016120632A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB1501612.4A 2015-01-30 2015-01-30 Assay Ceased GB201501612D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1501612.4A GB201501612D0 (en) 2015-01-30 2015-01-30 Assay
PCT/GB2016/050199 WO2016120632A1 (en) 2015-01-30 2016-01-29 Assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1501612.4A GB201501612D0 (en) 2015-01-30 2015-01-30 Assay

Publications (1)

Publication Number Publication Date
GB201501612D0 true GB201501612D0 (en) 2015-03-18

Family

ID=52705551

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1501612.4A Ceased GB201501612D0 (en) 2015-01-30 2015-01-30 Assay

Country Status (2)

Country Link
GB (1) GB201501612D0 (en)
WO (1) WO2016120632A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2607697C (en) * 2005-05-10 2015-01-06 Biogen Idec Ma Inc. Treating and evaluating inflammatory disorders
US7612181B2 (en) * 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
EP3217179B9 (en) * 2012-10-05 2020-06-10 Prometheus Biosciences, Inc. Methods for predicting and monitoring mucosal healing
WO2015006508A2 (en) * 2013-07-09 2015-01-15 The Translational Genomics Research Institute Compositions and methods of screening for compounds that modulate activity at a tweak binding site on a crd of fn14

Also Published As

Publication number Publication date
WO2016120632A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
IL259531B (en) Assay device
PL3311169T3 (en) Modulator assay
GB201403820D0 (en) Assay
HK1251621A1 (en) Biosensor
GB201514730D0 (en) Assay device
PL3245344T3 (en) Post-beam construction
GB201517458D0 (en) Assay
HK1247236A1 (en) Potency assay
AU361999S (en) Ballustrade
HK1254915A1 (en) Egfr assay
GB201614152D0 (en) Assay
GB201608364D0 (en) Assay
GB201605210D0 (en) Assay
GB201415343D0 (en) Blomarker assay
GB201514712D0 (en) Assay device
GB201419072D0 (en) Assay
GB201617175D0 (en) Assay
GB201511725D0 (en) Assay
GB201603359D0 (en) Improved assay
GB201514706D0 (en) Assay device
GB201616691D0 (en) Assay
GB201615746D0 (en) Nidogen-1 Assay
GB201512737D0 (en) Assay
GB201509300D0 (en) Assay
GB201608171D0 (en) Assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)